利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.027 秒)

    IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS AGALACTIAE
    2.
    发明申请
    IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS AGALACTIAE 审中-公开
    用于结核分枝杆菌的免疫组化

    公开(公告)号：US20100015168A1

    公开(公告)日：2010-01-21

    申请号：US12303999

    申请日：2007-06-11

    申请人： Domenico Maione ,  Guido Grandi ,  Nathalie Norais

    发明人： Domenico Maione ,  Guido Grandi ,  Nathalie Norais

    IPC分类号： A61K39/00 ,  G01N33/53 ,  C12N15/63 ,  C07K14/00 ,  C07H21/04

    CPC分类号： A61K39/092 ,  A61K38/00 ,  A61K39/00 ,  A61K2039/505 ,  C07K14/315 ,  G01N33/56944 ,  G01N2469/20

    摘要： The invention relates to immunogenic polypeptides derived from epitopes in a Streptococcus agalactiae (“GBS”) protein GBS 80 and their use as prophylactic, diagnostic and therapeutic compositions. The invention also provides nucleic acids encoding the immunogenic polypeptides. Also provided are vectors useful for making such immunogenic polypeptides and host cells transformed with such vectors. In particular, the invention relates to a group immunogenic polypeptides derived from GBS 80. The compositions may include one or more of the immunogenic polypeptides either alone or with other antigenic components. For example, the immunogenic polypeptides may be combined with other GBS antigens to provide therapeutic compositions with broader range. In addition, the immunogenic polypeptides may also include flanking portions of the GBS 80 protein.

    摘要翻译： 本发明涉及源自无乳链球菌（GBS）蛋白GBS 80中的表位的免疫原性多肽及其作为预防，诊断和治疗组合物的用途。 本发明还提供编码免疫原性多肽的核酸。 还提供了可用于制备这种免疫原性多肽的载体和用这些载体转化的宿主细胞。 特别地，本发明涉及衍生自GBS80的组免疫原性多肽。组合物可以单独或与其它抗原成分一起包括一种或多种免疫原性多肽。 例如，免疫原性多肽可以与其他GBS抗原组合以提供更宽范围的治疗组合物。 此外，免疫原性多肽还可以包括GBS 80蛋白的侧翼部分。

    IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS
    7.
    发明申请
    IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS 有权
    具有外膜蛋白的免疫细菌性细菌

    公开(公告)号：US20100015212A1

    公开(公告)日：2010-01-21

    申请号：US11666786

    申请日：2005-10-28

    申请人： Jeannette Adu-Bobie ,  Mariagrazia Pizza ,  Nathalie Norais ,  Germano Ferrari ,  Guido Grandi

    发明人： Jeannette Adu-Bobie ,  Mariagrazia Pizza ,  Nathalie Norais ,  Germano Ferrari ,  Guido Grandi

    IPC分类号： A61K9/127 ,  C12N1/20 ,  C12N1/00 ,  A61K35/04

    CPC分类号： C07K14/245 ,  A61K39/00 ,  A61K39/0258 ,  A61K39/095 ,  C07K14/22 ,  C12N9/1051 ,  Y02A50/474

    摘要： Knockout of the meningococcal mltA homolog gives bacteria that spontaneously release vesicles that are rich in immunogenic outer membrane proteins and that can elicit cross-protective antibody responses with higher bactericidal titres than OMVs prepared by normal production processes. Thus the invention provides a bacterium having a knockout mutation of its mltA gene. The invention also provides a bacterium, wherein the bacterium: (i) has a cell wall that includes peptidoglycan; and (ii) does not express a protein having the lytic transglycosylase activity of MltA protein. The invention also provides compositions comprising vesicles that, during culture of bacteria of the invention, are released into the culture medium.

    摘要翻译： 脑膜炎球菌mltA同系物的敲除使细菌自发释放富含免疫原性外膜蛋白的囊泡，并且能够以比正常生产过程制备的OMV更高的杀菌滴度引发交叉保护性抗体应答。 因此，本发明提供了具有其mltA基因的敲除突变的细菌。 本发明还提供了一种细菌，其中所述细菌：（i）具有包含肽聚糖的细胞壁; 和（ii）不表达具有MltA蛋白的裂解转糖苷酶活性的蛋白质。 本发明还提供包含囊泡的组合物，其在本发明的细菌培养期间释放到培养基中。

    Immunogenic bacterial vesicles with outer membrane proteins
    8.
    发明授权
    Immunogenic bacterial vesicles with outer membrane proteins 有权
    具有外膜蛋白的免疫原性细胞囊泡

    公开(公告)号：US09206399B2

    公开(公告)日：2015-12-08

    申请号：US11666786

    申请日：2005-10-28

    申请人： Jeannette Adu-Bobie ,  Mariagrazia Pizza ,  Nathalie Norais ,  Germano Ferrari ,  Guido Grandi

    发明人： Jeannette Adu-Bobie ,  Mariagrazia Pizza ,  Nathalie Norais ,  Germano Ferrari ,  Guido Grandi

    IPC分类号： A61K39/095 ,  C12N9/10 ,  A61K39/108

    CPC分类号： C07K14/245 ,  A61K39/00 ,  A61K39/0258 ,  A61K39/095 ,  C07K14/22 ,  C12N9/1051 ,  Y02A50/474

    摘要： Knockout of the meningococcal mltA homolog gives bacteria that spontaneously release vesicles that are rich in immunogenic outer membrane proteins and that can elicit cross-protective antibody responses with higher bactericidal titres than OMVs prepared by normal production processes. Thus the invention provides a bacterium having a knockout mutation of its mltA gene. The invention also provides a bacterium, wherein the bacterium: (i) has a cell wall that includes peptidoglycan; and (ii) does not express a protein having the lytic transglycosylase activity of MltA protein. The invention also provides compositions comprising vesicles that, during culture of bacteria of the invention, are released into the culture medium.

    摘要翻译： 脑膜炎球菌mltA同系物的敲除使细菌自发释放富含免疫原性外膜蛋白的囊泡，并且能够以比正常生产过程制备的OMV更高的杀菌滴度引发交叉保护性抗体应答。 因此，本发明提供了具有其mltA基因的敲除突变的细菌。 本发明还提供了一种细菌，其中所述细菌：（i）具有包含肽聚糖的细胞壁; 和（ii）不表达具有MltA蛋白的裂解转糖苷酶活性的蛋白质。 本发明还提供包含囊泡的组合物，其在本发明的细菌培养期间释放到培养基中。